{"id":3770,"date":"2026-11-17T18:46:30","date_gmt":"2026-11-17T18:46:30","guid":{"rendered":"https:\/\/tansan.com.tr\/?page_id=3770"},"modified":"2026-11-17T20:31:01","modified_gmt":"2026-11-17T20:31:01","slug":"kolon-kanseri-tedavisinde-yeni-gelismeler","status":"publish","type":"page","link":"https:\/\/tansan.com.tr\/en\/kolon-kanseri-tedavisinde-yeni-gelismeler\/","title":{"rendered":"New Developments in Colon Cancer Treatment"},"content":{"rendered":"<p>Kolon kanseri tedavisinde bug\u00fcn daha fazla se\u00e7ene\u011fimiz var; ancak \u00f6nemli olan, bu se\u00e7eneklerden hangisinin hangi hastaya yarar sa\u011flayaca\u011f\u0131n\u0131 belirlemek. Hastal\u0131\u011f\u0131n evresi, patoloji sonucu ve ki\u015finin genel sa\u011fl\u0131\u011f\u0131 birlikte de\u011ferlendiriliyor. Cerrahi, t\u0131bbi onkoloji, radyoloji ve patoloji uzmanlar\u0131n\u0131n ortak \u00e7al\u0131\u015fmas\u0131, hem ameliyat plan\u0131n\u0131 hem de ila\u00e7 tedavisinin zaman\u0131n\u0131 ve kapsam\u0131n\u0131 belirliyor. Karaci\u011fer veya akci\u011fere s\u0131n\u0131rl\u0131 yay\u0131l\u0131m\u0131 olan baz\u0131 hastalarda metastazlara y\u00f6nelik cerrahi ya da b\u00f6lgesel tedaviler de g\u00fcndeme gelebiliyor. [1]\n<p>Ki\u015fiye \u00f6zel tedavinin \u00f6nemli ad\u0131mlar\u0131ndan biri t\u00fcm\u00f6r\u00fcn molek\u00fcler \u00f6zelliklerini tan\u0131mak. MMR\/MSI incelemesi, kanser h\u00fccrelerinin DNA\u2019daki baz\u0131 hatalar\u0131 onarma yetene\u011fi hakk\u0131nda bilgi veriyor. Metastatik hastal\u0131kta RAS, BRAF ve gerekti\u011finde HER2 gibi hedeflerin de\u011ferlendirilmesi ila\u00e7 se\u00e7imini y\u00f6nlendiriyor. Bu sonu\u00e7lar, t\u00fcm\u00f6r\u00fcn sa\u011f veya sol kolondan ba\u015flamas\u0131 ve \u00f6nceki tedavilerle birlikte anlam kazan\u0131yor. [1]\n<p>Ameliyat sonras\u0131 tedavide 2026\u2019n\u0131n \u00f6nemli geli\u015fmelerinden biri ATOMIC \u00e7al\u0131\u015fmas\u0131 oldu. Lenf bezlerine yay\u0131lm\u0131\u015f, evre III ve DNA onar\u0131m kusuru ta\u015f\u0131yan (dMMR) kolon kanserinde, standart FOLFOX kemoterapisine atezolizumab adl\u0131 imm\u00fcnoterapinin eklenmesi hastal\u0131ks\u0131z ge\u00e7en s\u00fcreyi uzatt\u0131. Bu yakla\u015f\u0131m 2026\u2019da ABD\u2019de onay ald\u0131. Sonu\u00e7lar, b\u00fct\u00fcn evre III hastalara de\u011fil, bu belirli molek\u00fcler gruba ait. [2,3]\n<p>Ameliyat edilemeyen veya metastatik hastal\u0131kta da dMMR ya da y\u00fcksek mikrosatellit instabilitesi (MSI-H) saptanmas\u0131 tedavi se\u00e7imini de\u011fi\u015ftirebiliyor. Pembrolizumab\u0131n yan\u0131 s\u0131ra nivolumab ile ipilimumab\u0131n birlikte kullan\u0131m\u0131, uygun hastalarda uzun s\u00fcreli hastal\u0131k kontrol\u00fc sa\u011flayabilen se\u00e7enekler aras\u0131nda. Bu ikili tedavi 2025\u2019te ABD\u2019de onayland\u0131. Buna kar\u015f\u0131l\u0131k, bu \u00f6zellikleri ta\u015f\u0131mayan t\u00fcm\u00f6rlerde imm\u00fcnoterapi \u00e7o\u011funlukla standart bir se\u00e7enek de\u011fil. [1,4]\n<p>Hedefe y\u00f6nelik ila\u00e7larda da kullan\u0131m alanlar\u0131 geni\u015fliyor. BRAF V600E mutasyonlu metastatik hastal\u0131kta enkorafenib, setuksimab ve florourasil temelli kemoterapi birlikteli\u011fi 2026\u2019da ABD\u2019de tam onay ald\u0131. KRAS G12C mutasyonlu, daha \u00f6nce gerekli kemoterapileri alm\u0131\u015f hastalarda sotorasib ile panitumumab; HER2 pozitif, RAS mutasyonu bulunmayan ve \u00f6nceki tedaviler sonras\u0131nda ilerleyen uygun hastalarda ise tukatinib ile trastuzumab se\u00e7enek olabiliyor. Bu ila\u00e7lar, ilgili hedef saptand\u0131\u011f\u0131nda de\u011ferlendiriliyor. [5\u20137]\n<p>Ameliyat sonras\u0131nda kanda dola\u015fan t\u00fcm\u00f6r DNA\u2019s\u0131n\u0131n (ctDNA) ara\u015ft\u0131r\u0131lmas\u0131 da yak\u0131ndan izlenen bir alan. Bu test, geride kalabilecek mikroskobik hastal\u0131k ve tekrarlama riski hakk\u0131nda bilgi verebiliyor. Ancak DYNAMIC-III sonu\u00e7lar\u0131, evre III hastal\u0131kta yaln\u0131zca ctDNA sonucuna g\u00f6re kemoterapiyi azaltman\u0131n veya yo\u011funla\u015ft\u0131rman\u0131n her durumda daha iyi sonu\u00e7 vermedi\u011fini g\u00f6sterdi. Bu nedenle test, standart de\u011ferlendirmelerin yerine ge\u00e7en tek ba\u015f\u0131na bir karar arac\u0131 olarak g\u00f6r\u00fclmemeli. [8]\n<p>Yeni tedaviler umut veriyor; hastaya sa\u011flayacaklar\u0131 yarar ise do\u011fru se\u00e7ime ve d\u00fczenli takibe ba\u011fl\u0131. Tedavinin yan etkileri, ba\u011f\u0131rsak i\u015flevleri, beslenme ve g\u00fcnl\u00fck ya\u015fam \u00fczerindeki etkileri a\u00e7\u0131k\u00e7a konu\u015fulmal\u0131. Her se\u00e7enek T\u00fcrkiye\u2019deki eri\u015fim ko\u015fullar\u0131 da dikkate al\u0131narak, hastan\u0131n \u00f6ncelikleriyle birlikte de\u011ferlendirilmelidir.<\/p>\n<p><strong>Kaynaklar \u00a0<\/strong><a href=\"https:\/\/www.cancer.gov\/types\/colorectal\/hp\/colon-treatment-pdq\">[1] NCI \u00b7 Colon cancer<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC13020640\/\">[2] ATOMIC \u00b7 NEJM 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2026\/761034Orig1s065ltr.pdf\">[3] Atezolizumab \u00b7 FDA 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/cancer-approvals\/fda-approves-nivolumab-ipilimumab-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer\">[4] CheckMate-8HW \u00b7 FDA<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2026\/210496s019lbl.pdf\">[5] BRAF \u00b7 FDA 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/214665s009lbl.pdf\">[6] KRAS G12C \u00b7 FDA<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-tucatinib-trastuzumab-colorectal-cancer\">[7] HER2 \u00b7 FDA<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41115959\/\">[8] DYNAMIC-III<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kolon kanseri tedavisinde bug\u00fcn daha fazla se\u00e7ene\u011fimiz var; ancak \u00f6nemli olan, bu se\u00e7eneklerden hangisinin hangi hastaya yarar sa\u011flayaca\u011f\u0131n\u0131 belirlemek. Hastal\u0131\u011f\u0131n evresi, patoloji sonucu ve ki\u015finin genel sa\u011fl\u0131\u011f\u0131 birlikte de\u011ferlendiriliyor. Cerrahi, t\u0131bbi onkoloji, radyoloji ve patoloji uzmanlar\u0131n\u0131n ortak \u00e7al\u0131\u015fmas\u0131, hem ameliyat plan\u0131n\u0131 hem de ila\u00e7 tedavisinin zaman\u0131n\u0131 ve kapsam\u0131n\u0131 belirliyor. Karaci\u011fer veya akci\u011fere s\u0131n\u0131rl\u0131 yay\u0131l\u0131m\u0131 olan<\/p>","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3770","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Kolon Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tansan.com.tr\/en\/kolon-kanseri-tedavisinde-yeni-gelismeler\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kolon Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi\" \/>\n<meta property=\"og:description\" content=\"Kolon kanseri tedavisinde bug\u00fcn daha fazla se\u00e7ene\u011fimiz var; ancak \u00f6nemli olan, bu se\u00e7eneklerden hangisinin hangi hastaya yarar sa\u011flayaca\u011f\u0131n\u0131 belirlemek. Hastal\u0131\u011f\u0131n evresi, patoloji sonucu ve ki\u015finin genel sa\u011fl\u0131\u011f\u0131 birlikte de\u011ferlendiriliyor. Cerrahi, t\u0131bbi onkoloji, radyoloji ve patoloji uzmanlar\u0131n\u0131n ortak \u00e7al\u0131\u015fmas\u0131, hem ameliyat plan\u0131n\u0131 hem de ila\u00e7 tedavisinin zaman\u0131n\u0131 ve kapsam\u0131n\u0131 belirliyor. Karaci\u011fer veya akci\u011fere s\u0131n\u0131rl\u0131 yay\u0131l\u0131m\u0131 olan\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tansan.com.tr\/en\/kolon-kanseri-tedavisinde-yeni-gelismeler\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00d6zel Tansan Poliklini\u011fi\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-17T20:31:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/\",\"url\":\"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/\",\"name\":\"Kolon Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi\",\"isPartOf\":{\"@id\":\"https:\/\/tansan.com.tr\/#website\"},\"datePublished\":\"2026-11-17T18:46:30+00:00\",\"dateModified\":\"2026-11-17T20:31:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Ana sayfa\",\"item\":\"https:\/\/tansan.com.tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kolon Kanseri Tedavisinde Yeni Geli\u015fmeler\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tansan.com.tr\/#website\",\"url\":\"https:\/\/tansan.com.tr\/\",\"name\":\"Tansan Onkoloji - \u00d6zel Tansan Poliklini\u011fi\",\"description\":\"Kanser Te\u015fhis ve Tedavisi\",\"publisher\":{\"@id\":\"https:\/\/tansan.com.tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tansan.com.tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/tansan.com.tr\/#organization\",\"name\":\"\u00d6zel Tansan Onkoloji Poliklini\u011fi\",\"url\":\"https:\/\/tansan.com.tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png\",\"contentUrl\":\"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png\",\"width\":274,\"height\":66,\"caption\":\"\u00d6zel Tansan Onkoloji Poliklini\u011fi\"},\"image\":{\"@id\":\"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kolon Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tansan.com.tr\/en\/kolon-kanseri-tedavisinde-yeni-gelismeler\/","og_locale":"en_GB","og_type":"article","og_title":"Kolon Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","og_description":"Kolon kanseri tedavisinde bug\u00fcn daha fazla se\u00e7ene\u011fimiz var; ancak \u00f6nemli olan, bu se\u00e7eneklerden hangisinin hangi hastaya yarar sa\u011flayaca\u011f\u0131n\u0131 belirlemek. Hastal\u0131\u011f\u0131n evresi, patoloji sonucu ve ki\u015finin genel sa\u011fl\u0131\u011f\u0131 birlikte de\u011ferlendiriliyor. Cerrahi, t\u0131bbi onkoloji, radyoloji ve patoloji uzmanlar\u0131n\u0131n ortak \u00e7al\u0131\u015fmas\u0131, hem ameliyat plan\u0131n\u0131 hem de ila\u00e7 tedavisinin zaman\u0131n\u0131 ve kapsam\u0131n\u0131 belirliyor. Karaci\u011fer veya akci\u011fere s\u0131n\u0131rl\u0131 yay\u0131l\u0131m\u0131 olan","og_url":"https:\/\/tansan.com.tr\/en\/kolon-kanseri-tedavisinde-yeni-gelismeler\/","og_site_name":"\u00d6zel Tansan Poliklini\u011fi","article_modified_time":"2026-11-17T20:31:01+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/","url":"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/","name":"Kolon Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","isPartOf":{"@id":"https:\/\/tansan.com.tr\/#website"},"datePublished":"2026-11-17T18:46:30+00:00","dateModified":"2026-11-17T20:31:01+00:00","breadcrumb":{"@id":"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/tansan.com.tr\/kolon-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ana sayfa","item":"https:\/\/tansan.com.tr\/"},{"@type":"ListItem","position":2,"name":"Kolon Kanseri Tedavisinde Yeni Geli\u015fmeler"}]},{"@type":"WebSite","@id":"https:\/\/tansan.com.tr\/#website","url":"https:\/\/tansan.com.tr\/","name":"Tansan Oncology - Tansan Private Polyclinic","description":"Cancer Diagnosis and Treatment","publisher":{"@id":"https:\/\/tansan.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tansan.com.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/tansan.com.tr\/#organization","name":"Tansan Private Oncology Polyclinic","url":"https:\/\/tansan.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png","contentUrl":"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png","width":274,"height":66,"caption":"\u00d6zel Tansan Onkoloji Poliklini\u011fi"},"image":{"@id":"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/comments?post=3770"}],"version-history":[{"count":3,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3770\/revisions"}],"predecessor-version":[{"id":3797,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3770\/revisions\/3797"}],"wp:attachment":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/media?parent=3770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}